NCT05072275View on ClinicalTrials.gov

Prospective Electronic Polygenic Risk Study

UnknownOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions

Coronary Artery Disease

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Illumina, Inc.

INDUSTRY

collaborator

Quest Diagnostics-Nichols Insitute

INDUSTRY

lead

Scripps Translational Science Institute

OTHER